A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia

Acute myelogenous leukaemia (AML) is associated with risk factors that are largely unknown and with a heterogeneous response to treatment. Here, we provide a comprehensive quantitative understanding of AML proteomic heterogeneities and hallmarks by using the AML proteome atlas, a proteomics database...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, C. W., Qiu, Y., Ligeralde, A., Raybon, A.Y., Yoo, S. Y., Coombes, K. R., Qutub, A. A., Kornblau, S. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051028/
https://www.ncbi.nlm.nih.gov/pubmed/30988472
http://dx.doi.org/10.1038/s41551-019-0387-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051028/
https://www.ncbi.nlm.nih.gov/pubmed/30988472
http://dx.doi.org/10.1038/s41551-019-0387-2

Ejemplares similares